Park, K.; Kim, Y.; Son, M.; Chae, D.; Park, K.
A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer. Pharmaceutics 2022, 14, 914.
https://doi.org/10.3390/pharmaceutics14050914
AMA Style
Park K, Kim Y, Son M, Chae D, Park K.
A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer. Pharmaceutics. 2022; 14(5):914.
https://doi.org/10.3390/pharmaceutics14050914
Chicago/Turabian Style
Park, Kyemyung, Yukyung Kim, Mijeong Son, Dongwoo Chae, and Kyungsoo Park.
2022. "A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer" Pharmaceutics 14, no. 5: 914.
https://doi.org/10.3390/pharmaceutics14050914
APA Style
Park, K., Kim, Y., Son, M., Chae, D., & Park, K.
(2022). A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer. Pharmaceutics, 14(5), 914.
https://doi.org/10.3390/pharmaceutics14050914